The role of insulin in coronary atherosclerosis. 1994

S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
Second Department of Internal Medicine, Gunma University School of Medicine, Japan.

In 197 patients with coronary artery disease (CAD) who underwent coronary angiography, 75 g oral glucose tolerance test (OGTT) was performed, measuring plasma glucose(PG) and plasma insulin (IRI) at 4 time points (0, 30, 60 and 120 min). Subjects were separated into two groups by their insulinogenic index (I.I. = delta IRI/delta PG from 0 up to 30 min), 99 cases with good insulin response (I.I. > or = 0.4) and 98 cases with poor insulin response (I.I. < 0.4). Only two subjects were diabetic in good insulin response, while 37 were diabetic in poor insulin response. The severity of coronary atherosclerosis was expressed as a coronary index (CI), calculated according to Balcon's method. Fasting PG and the sum of PG were significantly higher in the latter group, while the sum of IRI was significantly lower. CI was not significantly different, however. In the group with good insulin response, the severity of CAD was significantly correlated to fasting IRI (n = 99, r = -0.387, P < 0.02), but, there was no such relationship in the other group. We conclude that hyperinsulinemia might be a risk factor for ischemic heart disease, but in diabetics it is difficult to link the relationship between fasting IRI and CI.

UI MeSH Term Description Entries
D006973 Hypertension Persistently high systemic arterial BLOOD PRESSURE. Based on multiple readings (BLOOD PRESSURE DETERMINATION), hypertension is currently defined as when SYSTOLIC PRESSURE is consistently greater than 140 mm Hg or when DIASTOLIC PRESSURE is consistently 90 mm Hg or more. Blood Pressure, High,Blood Pressures, High,High Blood Pressure,High Blood Pressures
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008076 Cholesterol, HDL Cholesterol which is contained in or bound to high-density lipoproteins (HDL), including CHOLESTEROL ESTERS and free cholesterol. High Density Lipoprotein Cholesterol,Cholesterol, HDL2,Cholesterol, HDL3,HDL Cholesterol,HDL(2) Cholesterol,HDL(3) Cholesterol,HDL2 Cholesterol,HDL3 Cholesterol,alpha-Lipoprotein Cholesterol,Cholesterol, alpha-Lipoprotein,alpha Lipoprotein Cholesterol
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D001794 Blood Pressure PRESSURE of the BLOOD on the ARTERIES and other BLOOD VESSELS. Systolic Pressure,Diastolic Pressure,Pulse Pressure,Pressure, Blood,Pressure, Diastolic,Pressure, Pulse,Pressure, Systolic,Pressures, Systolic
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases

Related Publications

S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
July 1996, Diabetes,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
June 2022, Lymphatic research and biology,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
February 2017, Current atherosclerosis reports,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
August 1996, Mayo Clinic proceedings,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
March 1979, Diabetologia,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
January 1962, Zdravookhranenie,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
January 1973, Advances in metabolic disorders,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
February 2010, Korean circulation journal,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
November 1998, Giornale italiano di cardiologia,
S Tomono, and N Kato, and T Utsugi, and T Ohno, and M Shimizu, and M Fukuda, and Y Itoh, and C Ishii, and S Kawazu
June 2010, Minerva cardioangiologica,
Copied contents to your clipboard!